RSCM
Rock Springs Capital Management Portfolio holdings
AUM
$1.6B
This Quarter Return
+8.38%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$1.6B
AUM Growth
+$1.6B
(-8.2%)
Cap. Flow
-$238M
Cap. Flow
% of AUM
-14.81%
Top 10 Holdings %
Top 10 Hldgs %
36.09%
Holding
105
New
9
Increased
32
Reduced
29
Closed
12
Top Buys
| 1 |
Agios Pharmaceuticals
AGIO
|
$21.5M |
| 2 |
CAI
Caris Life Sciences, Inc. Common Stock
CAI
|
$21.2M |
| 3 |
OMDA
Omada Health, Inc. Common Stock
OMDA
|
$16.8M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
$12.6M |
| 5 |
Arcellx
ACLX
|
$12.3M |
Top Sells
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$105M |
| 2 |
Nuvalent
NUVL
|
$25.5M |
| 3 |
Neurocrine Biosciences
NBIX
|
$23.9M |
| 4 |
Legend Biotech
LEGN
|
$17.4M |
| 5 |
UnitedHealth
UNH
|
$15.6M |
Sector Composition
| 1 | Healthcare | 98.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Warby Parker
WRBY
$3.2B
| – | – |
-835,000
| Closed | -$15.2M |
|
|
KMTS
102
Kestra Medical Technologies, Ltd. Common Stock
KMTS
$829M
| – | – |
-145,000
| Closed | -$3.61M |
|
|
SPRB
103
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-2,609,125
| Closed | -$757K |
|
|
NVRO
104
DELISTED
NEVRO CORP.
NVRO
| – | – |
-800,494
| Closed | -$4.67M |
|